摘要
目的:探索不同年龄段高血压患者的处方规律,为临床治疗决策和干预提供依据。方法:对我院2009年11月-2010年10月的高血压患者的处方进行分析,统计不同年龄段(<40、40~59、60~79、≥80岁)患者的就诊次数、用药频次、联合用药情况。结果:60~79岁年龄段的高血压患者1年中就诊次数最多,其中就诊5~8次和>8次的患者分别为25.45%和36.69%。40~59、60~79和≥80岁3个年龄段的患者单药使用的比例为38.33%、40.52%、46.68%,联合2种药物使用的比例为43.01%、38.35%、35.28%,血管紧张素Ⅱ受体拮抗药(ARB)和钙离子通道阻滞药(CCB)在处方中出现的频次分别为25.21%、29.17%、31.23%和31.41%、33.54%、41.80%。结论:随着年龄的增加,单药治疗高血压的处方不断增加,联合用药治疗高血压的处方不断减少,但ARB和CCB的用药频次随年龄的增加而增加。
To explore the characteristics of prescriptions of hypertensive patients with different ages to provide reference for clinical decision and interventions. METHODS: The prescriptions of hypertensive patients in our hospital during Nov. 2009--Oct. 2010 were analyzed. The number of visiting, frequency of drug use and drug combination were analyzed according to different age groups(〈40, 40-59, 60-79, ≥80 years). RESULTS: The highest number of one-year visiting appeared in patients aged 60-79 years. The percentage of patient to see a doctor 5-8 times per year and more than 8 times per year were 25.45% and 36.69%. For hypertensive patients of 3 age groups (40-59 years, 60-79 years, ≥-80 years), the proportions of single-drug ther- apy and 2 drugs combination therapy were 38.33%, 40.52%, 46.68% and 43.01%, 38.35%, 35.28%, respectively. The percentage of ARB and CCB were 25.21%, 29.17%, 31.23% and 31.41%, 33.54%, 41.80%. CONCLUSION: With increasing age, single-drug therapy for hypertension increases gradually. The combination therapy for hypertension continues to decline, the frequency of prescribing ARB and CCB increase gradually.
出处
《中国药房》
CAS
CSCD
北大核心
2011年第12期1125-1126,共2页
China Pharmacy
关键词
年龄
高血压
处方分析
Age
Hypertension
Prescription analysis